Bandavirus dabieense: A review of epidemiology, clinical characteristics, pathophysiology, treatment and prevention
- PMID: 40519175
- PMCID: PMC12184167
- DOI: 10.1080/21505594.2025.2520343
Bandavirus dabieense: A review of epidemiology, clinical characteristics, pathophysiology, treatment and prevention
Abstract
Bandavirus dabieense (commonly known as severe fever with thrombocytopenia syndrome virus, SFTSV) infection leads to severe fever with thrombocytopenia syndrome (SFTS), which is an emerging tick-borne natural focus disease discovered in middle-eastern China. SFTS is characterized by fever with thrombocytopenia, and patients' main clinical manifestations are leucopenia, elevated serum liver enzymes, and multiple organ failure. Ticks are considered as carriers of SFTSV transmission, and Haemaphysalis longicornalis is considered the main vector tick. SFTSV is disseminated through the migration or movement of tick-carrying migratory birds and other animal hosts. With changes in climate and environment, the habitat of ticks such as haemaphysalis longicornalis are continuously expanding, coupled with the diverse animal host species of the ticks. SFTS is evolving into a serious global public safety issue. In the absence of specific treatments and vaccines still being developed, monitoring and vector control are crucial for curbing the spread of SFTSV. Here, based on the existing literature, we reviewed the epidemiology, infection mechanism, clinical characteristics, diagnosis, prevention and clinical treatment of SFTSV to enhance the understanding of the SFTSV, with the aim of providing a theoretical basis guidance for the government and relevant institutions to prevent and control the further spread of SFTSV.
Keywords: Bandavirus dabieense; diagnosis; epidemiology; prevention; treatment.
Conflict of interest statement
No potential conflict of interest was reported by the author(s).
Figures




Similar articles
-
Smelly communication between haemaphysalis longicornis and infected hosts with indolic odorants: A case from severe fever with thrombocytopenia syndrome virus.PLoS Negl Trop Dis. 2025 Jun 5;19(6):e0013139. doi: 10.1371/journal.pntd.0013139. eCollection 2025 Jun. PLoS Negl Trop Dis. 2025. PMID: 40472053 Free PMC article.
-
Molecular mechanism of potently neutralizing human monoclonal antibodies against severe fever with thrombocytopenia virus infection.J Virol. 2025 Jul 22;99(7):e0053325. doi: 10.1128/jvi.00533-25. Epub 2025 Jun 20. J Virol. 2025. PMID: 40539781 Free PMC article.
-
Contributions of different host species to the natural transmission of severe fever with thrombocytopenia syndrome virus in China.PLoS Negl Trop Dis. 2025 Jul 17;19(7):e0013304. doi: 10.1371/journal.pntd.0013304. eCollection 2025 Jul. PLoS Negl Trop Dis. 2025. PMID: 40674441 Free PMC article.
-
Transmission of Severe Fever with Thrombocytopenia Syndrome (SFTS) to humans: A systematic review of individual participant data and meta-analysis.J Infect Public Health. 2025 Jun;18(6):102685. doi: 10.1016/j.jiph.2025.102685. Epub 2025 Jan 30. J Infect Public Health. 2025. PMID: 40073663
-
Systematic review of severe fever with thrombocytopenia syndrome: virology, epidemiology, and clinical characteristics.Rev Med Virol. 2014 Mar;24(2):90-102. doi: 10.1002/rmv.1776. Epub 2013 Dec 6. Rev Med Virol. 2014. PMID: 24310908 Free PMC article.
Cited by
-
Advances in research on severe fever with thrombocytopenia syndrome virus.Front Microbiol. 2025 Jul 23;16:1622394. doi: 10.3389/fmicb.2025.1622394. eCollection 2025. Front Microbiol. 2025. PMID: 40771693 Free PMC article. Review.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources